Unibioscreen S.A. – Product Pipeline Review – Q1 2011

Document Sample
Unibioscreen S.A. – Product Pipeline Review – Q1 2011 Powered By Docstoc
					       Unibioscreen S.A. – Product Pipeline Review – Q1
                                                                                          Reference Code: GMDHC0966CDB

                                                                                                Publication Date: MAR 2011

Unibioscreen S.A. – Product Pipeline Review – Q1 2011                                       GMDHC0966CDB / Published MAR 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Unibioscreen S.A. – Product Pipeline Review

Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        3
List of Figures                                                                                                       3
Unibioscreen S.A. Snapshot                                                                                            4
    Unibioscreen S.A. Overview                                                                                        4
    Key Information                                                                                                   4
    Key Facts                                                                                                         4
Unibioscreen S.A. – Research and Development Overview                                                                 5
    Key Therapeutic Areas                                                                                             5
Unibioscreen S.A. – Pipeline Review                                                                                   8
    Pipeline Products by Stage of Development                                                                         8
    Pipeline Products – Monotherapy                                                                                   9
Unibioscreen S.A. – Pipeline Products Glance                                                                         10
    Unibioscreen S.A. Clinical Stage Pipeline Products                                                               10
         Phase I Products/Combination Treatment Modalities                                                           10
    Unibioscreen S.A.–Early Stage Pipeline Products                                                                  11
         Pre-Clinical Products/Combination Treatment Modalities                                                      11
         Discovery Products/Combination Treatment Modalities                                                         12
Unibioscreen S.A. – Drug Profiles                                                                                    13
    UNBS1450                                                                                                         13
         Product Description                                                                                         13
         Mechanism of Action                                                                                         13
         R&D Progress                                                                                                13
    UNBS1070                                                                                                         14
         Product Description                                                                                         14
         Mechanism of Action                                                                                         14
         R&D Progress                                                                                                14
    UNBS1450                                                                                                         15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    UNBS3078                                                                                                         16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    UNBS3243                                                                                                         17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    UNBS5200                                                                                                         18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18
Unibioscreen S.A. – Pipeline Analysis                                                                                19
    Unibioscreen S.A. – Pipeline Products by Therapeutic Class                                                       19
    Unibioscreen S.A. - Pipeline Products By Target                                                                  20

Unibioscreen S.A. – Product Pipeline Review – Q1 2011                                     GMDHC0966CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Unibioscreen S.A. – Product Pipeline Review

    Unibioscreen S.A. – Pipeline Products by Route of Administration                                                                                                                               21
    Unibioscreen S.A. – Pipeline Products by Molecule Type                                                                                               
Description: Unibioscreen S.A. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Unibioscreen S.A. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Unibioscreen S.A. - Brief company overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Unibioscreen S.A. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Unibioscreen S.A. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Unibioscreen S.A.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Unibioscreen S.A.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Unibioscreen S.A. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Unibioscreen S.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity
PARTNER GlobalMarketsDirect
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Global Markets Direct has a broad range of coverage over key market segments. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries